Adalimumab Solution for Injection
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's DiseaseSevere Plaque Psoriasis in Chinese Children
Phase 4
A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis
Not yet recruitingNCT07529925
Start: 2026-05-01End: 2028-05-01Target: 30Updated: 2026-04-14
A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease
RecruitingNCT07564505
Start: 2026-08-13End: 2029-03-01Target: 30Updated: 2026-09-10